PNC Financial Services Group Inc. Trims Stake in Option Care Health, Inc. (NASDAQ:OPCH)

PNC Financial Services Group Inc. lowered its stake in Option Care Health, Inc. (NASDAQ:OPCH) by 25.9% during the first quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 21,377 shares of the company’s stock after selling 7,463 shares during the quarter. PNC Financial Services Group Inc.’s holdings in Option Care Health were worth $747,000 as of its most recent filing with the SEC.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Public Employees Retirement System of Ohio lifted its stake in Option Care Health by 21.6% in the 4th quarter. Public Employees Retirement System of Ohio now owns 1,870 shares of the company’s stock valued at $43,000 after buying an additional 332 shares in the last quarter. Johnson Financial Group Inc. acquired a new position in Option Care Health in the 4th quarter valued at $47,000. Bessemer Group Inc. raised its holdings in Option Care Health by 62.3% in the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock valued at $54,000 after acquiring an additional 599 shares during the last quarter. Wealthquest Corp acquired a new position in Option Care Health in the 1st quarter valued at $66,000. Finally, Farther Finance Advisors LLC raised its holdings in Option Care Health by 434.8% in the 1st quarter. Farther Finance Advisors LLC now owns 1,920 shares of the company’s stock valued at $67,000 after acquiring an additional 1,561 shares during the last quarter. Hedge funds and other institutional investors own 98.05% of the company’s stock.

Analysts Set New Price Targets

Several research analysts have weighed in on OPCH shares. JMP Securities boosted their price target on Option Care Health from $36.00 to $38.00 and gave the company a “market outperform” rating in a report on Thursday, July 31st. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a report on Thursday, July 31st. UBS Group upgraded Option Care Health from a “neutral” rating to a “buy” rating and boosted their price target for the company from $38.00 to $40.00 in a report on Wednesday, April 30th. Finally, Barrington Research reiterated an “outperform” rating and issued a $38.00 price target on shares of Option Care Health in a report on Thursday, July 10th. One investment analyst has rated the stock with a hold rating and eight have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $35.75.

Option Care Health Trading Down 1.2%

OPCH stock opened at $27.85 on Tuesday. The company has a market cap of $4.52 billion, a price-to-earnings ratio of 22.28, a PEG ratio of 1.78 and a beta of 0.79. The company has a quick ratio of 1.00, a current ratio of 1.52 and a debt-to-equity ratio of 0.81. The business has a fifty day simple moving average of $30.56 and a 200-day simple moving average of $31.93. Option Care Health, Inc. has a 52 week low of $21.39 and a 52 week high of $35.53.

Option Care Health (NASDAQ:OPCH) last released its quarterly earnings data on Wednesday, July 30th. The company reported $0.41 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.01. The business had revenue of $1.42 billion during the quarter, compared to the consensus estimate of $1.35 billion. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%. The business’s revenue for the quarter was up 15.4% on a year-over-year basis. During the same period in the prior year, the firm posted $0.30 EPS. On average, equities research analysts expect that Option Care Health, Inc. will post 1.22 EPS for the current year.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.